Erratum to: Ex vivo bio-compatibility of honey-alginate fibrous matrix for HaCaT and 3T3 with prime molecular expressions[J Mater Sci: Mater Med, 10.1007/s10856-011-4456-7];Ex vivo bio-compatibility of honey-alginate fibrous matrix for HaCaT and 3T3 with prime molecular expressions

Journal of Materials Science: Materials in Medicine

Volumn 25, Issue 12, 2014, Pages 2659-2667

  Barui, Ananya ^a   Khare, Ritesh ^a   Dhara, Santanu ^a   Banerjee, Provas ^a,b   Chatterjee, Jyotirmoy ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

^b Banerjee's Biomedical Research Foundation   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINATE; CALCIUM COMPOUNDS; CELL ADHESION; FOOD PRODUCTS; MOLECULES; TISSUE;

ALGINATE SCAFFOLDS; BIOLOGICAL PERFORMANCE; CELL ADHESION MOLECULES; CELLULAR ADHERENCES; EXTRACELLULAR MATRICES; MORPHOLOGICAL PROPERTIES; THERAPEUTIC EFFICACY; TISSUE ENGINEERING APPLICATIONS;

SCAFFOLDS (BIOLOGY);

ALGINIC ACID; BIOMATERIAL; CELL ADHESION MOLECULE; GLUCURONIC ACID; HEXURONIC ACID; SCLEROPROTEIN;

3T3 CELL LINE; ANIMAL; CELL ADHESION; CELL LINE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DEVICES; DRUG EFFECTS; HONEY; HUMAN; KERATINOCYTE; MATERIALS TESTING; METABOLISM; MOUSE; PHYSIOLOGY; TISSUE ENGINEERING; TISSUE SCAFFOLD;

3T3 CELLS; ALGINATES; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE; CELL PROLIFERATION; EXTRACELLULAR MATRIX PROTEINS; GLUCURONIC ACID; HEXURONIC ACIDS; HONEY; HUMANS; KERATINOCYTES; MATERIALS TESTING; MICE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84912530807     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-014-5320-3     Document Type: Erratum

References (48)

1. Lutolf MP, Hubbel JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005;23:47–55.
2. Mohan N, Nair PD. Novel porous, polysaccharide scaffolds for tissue engineering applications. Trends Biomater Artif Organs. 2005;18:219–24.
3. Sachlos E, Czernuszka JT. Making tissue engineering scaffolds work. Review on the application of solid freeform fabrication technology to the production of tissue engineering scaffolds. Eur Cell Mater. 2003;5:29–40.
4. Langer R, Tirrell DA. Designing materials for biology and medicine. Nature. 2004;428:487–92.
5. Chen G, Ushida T, Tateishi T. Development of biodegradable porous scaffolds for tissue engineering. Mater Sci Eng. 2001;17:63–9.
6. Wang Y, Liu L, Guo S. Characterization of biodegradable and cytocompatible nano-hydroxyapatite/polycaprolactone porous scaffolds in degradation in vitro. Polymer Degrad Stabil. 2010;95(2):207–13.
7. Mata A, Kim EJ, Boehm CA, Fleischman AJ, Muschler GF, Roy SA. Three-dimensional scaffold with precise micro-architecture and surface micro-textures. Biomaterials. 2009;30:4610–7.
8. Stella JA, Liao J, Hong Y, Merryman WD, Wagner WR. Tissue-to-cellular level deformation coupling in cell micro-integrated elastomeric scaffolds. Biomaterials. 2008;29:3228–36.
9. Michael S, SacksQuaglia F. Bioinspired tissue engineering: the great promise of protein delivery technologies. Int J Pharm. 2008;364:281–97.
10. Mandal BB, Kundu S. Biospinning by silkworms: silk fiber matrices for tissue engineering applications. Acta Biomater. 2010;6(2):360–71.
11. Mo XM, Xu CY, Kotaki MR. Electrospun P (LLA-CL) nanofiber: a biomimetic extracellular matrix for smooth muscle cell and endothelial cell proliferation. Biomaterials. 2004;25:1883–90.
12. Place ES, Evans ND, Stevens MM. Complexity in biomaterials for tissue engineering. Nature Materials. 2009;8:457–70.
13. Lia Z, Ramaya HR, Hauchb KD, Xiaoc D, Zhang M. Chitosan–alginate hybrid scaffolds for bone tissue engineering. Biomaterials. 2005;26:3919–28.
14. Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials. 2003;24:4337–51.
15. Riva BD, Nowak C, Sánchez E, Hernández A, Siegmund MS, Pec MK, Delgado A, Évora C. VEGF-controlled release within a bone defect from alginate/chitosan/PLA-H scaffolds. Eur J Pharm Biopharm. 2009;73:50–8.
16. Harley BAC, Gibson LJ. In vivo and in vitro applications of collagen-GAG scaffolds. Chem Eng J. 2008;137:102–21.
17. Dai W, Kawazoe N, Lin X, Dong J, Chen G. The influence of structural design of PLGA/collagen hybrid scaffolds in cartilage tissue engineering. Biomaterials. 2010;31(8):2141–52.
18. Draget KI, Taylor C. Chemical, physical and biological properties of alginates and their biomedical implications. Food Hydrocolloids. 2011;25(2):251–6.
19. Hwang YS, Cho J, Tay F, Heng JY, Ho R, Kazarian SG, Williams DR, Boccaccini AR, Polak JM, Mantalaris A. The use of murine embryonic stem cells, alginate encapsulation, and rotary microgravity bioreactor in bone tissue engineering. Biomaterials. 2009;30:499–507.
20. Kuo CK, Ma PX. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1 Structure, gelation rate and mechanical properties. Biomaterials. 2001;22:511–21.
21. Yusha QI, Lu LU. Purification of alginate for tissue engineering. IEEE 2009;1–4.
22. Soni ML, Kumar M, Namdeo KP. Sodium alginate microspheres for extending drug release: formulation and in vitro evaluation. Int J Drug Deliv. 2010;2:64–8.
23. Bouhadir KH, Lee KY, Alsberg E, Damm KL, Anderson KW, Mooney DJ. Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog. 2001;17:945–50.
24. Hunt NC, Shelton RM, Grover L. An alginate hygrogel matrix for the localized delivery of a fibroblast/keratinocyte co-culture. Biotechnol J. 2009;4:730–7.
25. Ko HF, Sfeir C, Kumta PN. Novel synthesis strategies for natural polymer and composite biomaterials as potential scaffolds for tissue engineering. Phil Trans R Soc A. 2010;368:1981–97.
26. Bansal V, Medhi B, Pandhi P. Honey-A remedy rediscovered and its therapeutic utility. Kathmandu Univ Med J. 2005;3:305–9.
27. Lord A. Sweet healing. New Scientist 2000;32–35.
28. Visavadia BG, Honeysett J, Danford HM. Manuka honey dressing: an effective treatment for chronic wound infections. Br J Oral Maxillofac Surg. 2008;46(1):55–6.
29. Foroughi J, Spinks GM, Wallace GG, Whitten PG. Production of polypyrrole fibres by wet spinning. Synth Metals. 2008;158:104–7.
30. Watthanaphanit A, Supaphol P, Tamura H, Tokura S, Rujiravanit R. Wet-spun alginate/chitosan whiskers nanocomposite fibers: preparation, characterization and release characteristic of the whiskers. Carbohydr Polym. 2010;79:738–46.
31. Nadeem F, Slominski A, Choudhry AM, Wei TE, Sayeed MM. Effect of CRF and related peptides on calcium signalling in human and rodent melanoma cells. FEBS Lett. 1998;435:187–90.
32. Tang A, Eller MS, Hara M, Yaar M, Hirohashi S, Gilchrest BA. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci. 1994;107:983–92.
33. Korossis SA, Bolland F, Kearney JN, Fisher J, Ingham E. Bioreactors in tissue engineering. In: Ashammakhi N, Reis RL, editors. Topics in tissue engineering. 2005.
34. Jiang H, Grinnell F. Cell–matrix entanglement and mechanical anchorage of fibroblasts in three-dimensional collagen matrices. Mol Biol Cell. 2005;16:5070–6.
35. Krell R. Value-added products from beekeeping. Food and agriculture organization of the United Nations Rome, 1996.
36. Gonzalez RC, Woods RE. Digital image processing. New York: Prentice hall; 2002. p. 595–612.
37. Ruozia B, Parmab B, Crocec MA, Tosi G, Bondiolia L, Vismarab S, Fornia F, Vandellia MA. Collagen-based modified membranes for tissue engineering: Influence of type and molecular weight of GAGs on cell proliferation. Int J Pharm. 2009;378:108–15.
38. Gun AM, Gupta MK, Dasgupta B. An outline of statistical theory. 3rd ed. Kolkata: The world press private Ltd; 2005.
39. Vogt S, Larcher Y, Beer B, Wilke I, Schnabelrauch M. Fabrication of highly porous scaffold materials based on functionalized oligolactides and preliminary results on their use in bone tissue engineering. Eur Cell Mater. 2002;4:30–8.
40. Bhattarai N, Zhang M. Controlled synthesis and structural stability of alginate-based nanofibers. Nanotechnology. 2007;18:455601–12.
41. Nair LS and Laurencin CT. Polymers as biomaterials for tissue engineering and controlled drug delivery. Adv Biochem Engin/Biotechnol, 102: 47–90. Springer-Verlag Berlin, 2005.
42. Mumper RJ, Huffman AS, Puolakkainen PA, Bouchard LS, Gombotz WR. Calcium-alginate beads for the oral delivery of transforming growth factor beta (1) by the addition of polyacrylic-acid within acid treated beads. J Control Release. 1994;30:241–51.
43. Kim GH, Ahn S, Kim YY, Cho Y, Chun W. Coaxial structured collagen–alginate scaffolds: fabrication, physical properties, and biomedical application for skin tissue regeneration. J Mater Chem. 2011;21:6165–72.
44. Cuy J. Biomaterials tutorial: natural polymers. University of Washington Engineered Biomaterials. http://www.uweb.engr.washington.edu, 2004.
45. Grace M, Chand N, Bajpai SK. Copper Alginate-Cotton Cellulose (CACC) fibers with excellent antibacterial properties. J Eng Fiber Fabrics. 2009;4:24–35.
46. Smetana KJ. Cell biology of hydrogels. Biomaterials. 1993;14:1046–50.
47. Sell SA, Wolfe S, Garg K, McCool JM, Rodriguez IA, Bowlin GL. The use of natural polymers in tissue engineering: a focus on electrospun extracellular matrix analogues. Polymers. 2010;2:522–53.
48. Nawrocki B, Polette M, Hengel JV, Tournier JM, Roy FV, Birembau P. Cytoplasmic redistribution of E-Cadherin-Catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas. Am J Pathol. 1998;5:1521–30.